A performance-oriented executive with expertise in global Medical Scientific Affairs and Clinical Development from the Pre-IND filing stage to NDA filing. Highly strategic thinker. I have led the discovery of novel molecules & commercialization of novel pharmaceutical products in Oncology, Hematology, BiTE and CAR-T Cell technologies, Small Molecules, Men’s and Women’s Health, Gene Editing, CRISPR, CNS, and Endocrine systems.

Robert has been appointed as Vice President, Clinical Research & Development. “Robert’s proven ability to develop and implement successful clinical development strategies aligned with regulatory, CMC, and Clinical Operation strategies for novel hematology and oncology candidates at various stages has been a significant asset. Dr. Imani brings more than two decades of leadership in clinical research and development, medical scientific affairs, and drug safety (PV&RM) in the United States and the Netherlands. He has amassed his experience during roles at many notable industry leaders, including Senior Medical Director at Abbott Laboratories, Associate Medical Director at Forest Research Institute, a Subsidiary of Forest Laboratories, Inc., Neurocrine Biosciences, Inc., and OSI Pharmaceuticals, Inc., and most recently as Executive Medical Director at Onyx Pharmaceuticals, Inc. and Amgen Inc.

Robert has led global product development teams in 3 regions around the globe from proof of concept to marketing authorization and LCM of blockbuster assets after successful launch (e.g. Kyprolis, Blincyto, Tarceva, Nexavar, Lupron, Orilissa, and more than 10 other approved compounds).

Led Phase I, Phase IIa, and IIb, and late-stage Phase III and IV clinical trials. Previously served as Executive Medical Director, medical lead, and medical monitory and safety officer at Allergan (FRX), OSI Oncology, Neurocrine, and Daniel Den Hoed Cancer Center.

  • Expert in Statistics, Study design, Clinical Outline, Study Synopsis, and Protocol.
  • Prediction Models, Biomarkers development, detection, and validation.
  • Subject matter expert in NGS, MRD, Diagnostic and Prognostic tests
  • Stanford University School of Medicine Graduate
  • Post-doctorate Fellowship from Stanford University Gynecology Department
  • Gynecology & Obstetrics Residency
  • MD – Ph.D. in Reproductive Medicine
  • Authored over 30 abstracts & publications
  • Co-Investigator (EU and US) and co-chair of international societies